These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
147 related articles for article (PubMed ID: 22948779)
1. A clinical study on regional lymphatic chemotherapy using an activated carbon nanoparticle-epirubicin in patients with breast cancer. Yang Q; Wang XD; Chen J; Tian CX; Li HJ; Chen YJ; Lv Q Tumour Biol; 2012 Dec; 33(6):2341-8. PubMed ID: 22948779 [TBL] [Abstract][Full Text] [Related]
2. Evaluation of the tracing effect of carbon nanoparticle and carbon nanoparticle-epirubicin suspension in axillary lymph node dissection for breast cancer treatment. Du J; Zhang Y; Ming J; Liu J; Zhong L; Liang Q; Fan L; Jiang J World J Surg Oncol; 2016 Jun; 14(1):164. PubMed ID: 27335011 [TBL] [Abstract][Full Text] [Related]
3. [Impact of preoperative lymphatic chemotherapy on relapse and metastasis of breast cancer and its mechanism]. Wu WJ; Zeng J; Lu YF; Jiang WZ; Chen L; Pan CE Ai Zheng; 2005 Dec; 24(12):1537-41. PubMed ID: 16351809 [TBL] [Abstract][Full Text] [Related]
4. [Efficacy of activated charcoal-epirubicin suspension for treatment of breast cancer with axillary metastasis]. Wu WJ; Zeng J; Pan CE Nan Fang Yi Ke Da Xue Xue Bao; 2006 Dec; 26(12):1812-4. PubMed ID: 17259127 [TBL] [Abstract][Full Text] [Related]
5. [Effect of preoperative lymphatic chemotherapy on Bcl-2 and Bax expression in axillary metastasis of breast cancer]. Wu WJ; Pan CE; Zeng J Di Yi Jun Yi Da Xue Xue Bao; 2005 Aug; 25(8):1001-4. PubMed ID: 16109560 [TBL] [Abstract][Full Text] [Related]
6. [Drug concentration in axillary lymph nodes of patients with breast cancer after lymphatic chemotherapy]. Chen JH; Yang YM; Li KZ; Ling R; Yao Q; Yang H Ai Zheng; 2005 Apr; 24(4):494-7. PubMed ID: 15820077 [TBL] [Abstract][Full Text] [Related]
7. Drug concentrations in axillary lymph nodes after lymphatic chemotherapy on patients with breast cancer. Chen J; Wang L; Yao Q; Ling R; Li K; Wang H Breast Cancer Res; 2004; 6(4):R474-7. PubMed ID: 15217515 [TBL] [Abstract][Full Text] [Related]
8. Dose-dense adjuvant chemotherapy in node-positive breast cancer: docetaxel followed by epirubicin/cyclophosphamide (T/EC), or the reverse sequence (EC/T), every 2 weeks, versus docetaxel, epirubicin and cyclophosphamide (TEC) every 3 weeks. AERO B03 randomized phase II study. Piedbois P; Serin D; Priou F; Laplaige P; Greget S; Angellier E; Teissier E; Berdah JF; Fabbro M; Valenza B; Herait P; Jehl V; Buyse M Ann Oncol; 2007 Jan; 18(1):52-57. PubMed ID: 17047001 [TBL] [Abstract][Full Text] [Related]
9. Lymphatic chemotherapy induces apoptosis in lymph node metastases in a rabbit breast carcinoma model. Ling R; Li Y; Yao Q; Chen T; Zhu D; Jun Y; Chen J J Drug Target; 2005 Feb; 13(2):137-42. PubMed ID: 15823965 [TBL] [Abstract][Full Text] [Related]
10. [Comparison of sentinel lymph node detection by methylene blue and carbon nanoparticle suspension injection in early breast cancer]. Ge J; Yan B; Cao XC Zhonghua Zhong Liu Za Zhi; 2011 Mar; 33(3):226-8. PubMed ID: 21575525 [TBL] [Abstract][Full Text] [Related]
11. Colorectal cancer lymph node staining by activated carbon nanoparticles suspension in vivo or methylene blue in vitro. Cai HK; He HF; Tian W; Zhou MQ; Hu Y; Deng YC World J Gastroenterol; 2012 Nov; 18(42):6148-54. PubMed ID: 23155345 [TBL] [Abstract][Full Text] [Related]
12. Prognostic, predictive abilities and concordance of BCL2 and TP53 protein expression in primary breast cancers and axillary lymph-nodes: a retrospective analysis of the Belgian three arm study evaluating anthracycline vs CMF adjuvant chemotherapy. Bozovic-Spasojevic I; Ameye L; Paesmans M; Larsimont D; Di Leo A; Dolci S; Piccart M; de Azambuja E; Loi S Breast; 2014 Aug; 23(4):473-81. PubMed ID: 24768477 [TBL] [Abstract][Full Text] [Related]
13. Lymphatic-targeted therapy following neoadjuvant chemotherapy: a promising strategy for lymph node-positive breast cancer treatment. Chen J; Yao Q; Wang H; Wang B; Zhang J; Wang T; Lv Y; Han Z; Wang L Med Oncol; 2015 Jul; 32(7):184. PubMed ID: 26008153 [TBL] [Abstract][Full Text] [Related]
14. Nano Carbon Tracing-based Treatment of Breast Cancer Lymphadenectomy and Nursing Intervention of Postoperative Lymphedema. Li X; Fu H; Li P; Li Y; Li W; Zhu F Cell Mol Biol (Noisy-le-grand); 2022 Mar; 68(3):304-313. PubMed ID: 35988167 [TBL] [Abstract][Full Text] [Related]
15. Dose-dense adjuvant chemotherapy with epirubicin monotherapy in patients with operable breast cancer and >/=10 positive axillary lymph nodes. A feasibility study. Fountzilas G; Nicolaides C; Aravantinos G; Skarlos D; Kosmidis P; Papakostas P; Stathopoulos GP; Kontostolis E; Bafaloukos D; Pavlidis N Oncology; 1998; 55(6):508-12. PubMed ID: 9778614 [TBL] [Abstract][Full Text] [Related]
16. Effect of Neoadjuvant Chemotherapy on Axillary Lymph Node Positivity and Numbers in Breast Cancer Cases. Uyan M; Koca B; Yuruker S; Ozen N Asian Pac J Cancer Prev; 2016; 17(3):1181-5. PubMed ID: 27039745 [TBL] [Abstract][Full Text] [Related]
17. Computed tomography reconstruction for evaluating response in axillary lymph nodes of breast cancer after neoadjuvant chemotherapy. Wang L; Li Y; Li J; Wang T; Xie Y; He Y; Fan Z; Ouyang T Clin Transl Oncol; 2021 Feb; 23(2):240-245. PubMed ID: 32519177 [TBL] [Abstract][Full Text] [Related]
18. Effect of preoperative injection of carbon nanoparticle suspension on the outcomes of selected patients with mid-low rectal cancer. Zhang XM; Liang JW; Wang Z; Kou JT; Zhou ZX Chin J Cancer; 2016 Apr; 35():33. PubMed ID: 27044280 [TBL] [Abstract][Full Text] [Related]
19. Identification and evaluation of axillary sentinel lymph nodes in patients with breast carcinoma treated with neoadjuvant chemotherapy. Cohen LF; Breslin TM; Kuerer HM; Ross MI; Hunt KK; Sahin AA Am J Surg Pathol; 2000 Sep; 24(9):1266-72. PubMed ID: 10976701 [TBL] [Abstract][Full Text] [Related]
20. Ultrasound-Guided Restaging and Localization of Axillary Lymph Nodes After Neoadjuvant Chemotherapy for Guidance of Axillary Surgery in Breast Cancer Patients: Experience with Activated Charcoal. Kim WH; Kim HJ; Jung JH; Park HY; Lee J; Kim WW; Park JY; Chae YS; Lee SJ Ann Surg Oncol; 2018 Feb; 25(2):494-500. PubMed ID: 29134374 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]